Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate.
Par Drugs and Chemicals Limited (PAR) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The PAR share price is ₹109.00 (-2.50% today), with a market capitalisation of ₹1B and a price-to-earnings (P/E) ratio of 10.2. MarketRipple tracks the PAR investment thesis, the ripple-chain impact of market events on Par Drugs and Chemicals Limited, and the Healthcare sector outlook.
Open
₹111.48
High
₹111.48
Low
₹108.10
Prev. Close
₹111.80
52W High
₹180.00
52W Low
₹78.05
Day range
₹108.10–₹111.48
52-week range
₹78.05–₹180.00
Volume
2K
P/E
10.2
ROE
11.5%
D/E
0.00
Margin
12.1%
Par Drugs and Chemicals Limited (NSE: PAR) is currently trading at ₹109.00 (-2.50%).
Par Drugs and Chemicals Limited's market capitalization is ₹1B.
Par Drugs and Chemicals Limited's price-to-earnings (P/E) ratio is 10.2.
Par Drugs and Chemicals Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).